查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466734

軟骨修復/軟骨再生市場：按治療模式、應用和最終用戶分類 - 全球預測 2024-2030

Cartilage Repair/Cartilage Regeneration Market by Treatment Mode (Cell-Based, Non-Cell-Based), Application (Fibrocartilage, Hyaline Cartilage), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

軟骨修復/軟骨再生市場規模預估2023年為18.3億美元，2024年達20.6億美元，預估2030年將達44.6億美元，複合年成長率為13.55%。

軟骨修復和再生是指各種旨在恢復受損關節軟骨的功能和減輕疼痛的醫療治療和程序。軟骨是一種光滑、有彈性的組織。這種橡膠墊片覆蓋並保護關節中長骨的末端，包括胸腔、耳朵、鼻子、支氣管、椎間盤和身體的許多其他部位。軟骨修復和再生市場包括旨在修復、再生和替換受損軟骨的醫療程序、工具和治療方法。關節炎和骨關節炎等骨關節疾病的流行，以及交通事故和運動相關傷害的快速增加正在推動市場成長。人們對軟骨生理學、解剖學和修復技術的認知不斷提高也推動了市場的發展。與軟骨修復手術相關的成本以及與軟骨修復和再生手術相關的風險和併發症限制了市場的開拓。軟骨再生裝置的技術進步正在提高再生治療的有效性。此外，對軟骨再生的持續研究和開發正在擴大其成長潛力。

主要市場統計
基準年[2023] 18.3億美元
預測年份 [2024] 20.6億美元
預測年份 [2030] 44.6億美元
複合年成長率（%） 13.55%

治療模式 年輕患者首選細胞治療方法

細胞療法使用活細胞來修復和再生軟骨組織。這些治療方法通常利用軟骨細胞和可分化為軟骨細胞的間質幹細胞。使用細胞的軟骨細胞移植是針對軟骨缺陷和損傷的先進醫學治療方法，通常用於局部軟骨缺陷的患者。這個過程包括從患者體內收集健康的軟骨細胞，在實驗室中培養這些細胞，然後將它們重新移植到受傷部位。生長因子技術應用已知可促進細胞（包括軟骨細胞）生長和分化的特定蛋白質。這些生物分子可以透過多種方式施用，包括注射或植入支架。另一方面，無細胞治療方法包括不直接使用活細胞的治療方法，例如有助於軟骨自然修復過程的組織支架和生長因子。無細胞複合材料是指無需直接使用活細胞即可實現軟骨組織再生的生物材料。相反，這些材料旨在模擬細胞外基質並支持天然細胞遷移和增殖到缺陷部位。組織支架是3D結構，為新軟骨組織的生長和發育提供支持環境。這些支架可以是生物分解性的或非生物分解的，並由多種材料製成，包括天然和合成聚合物、陶瓷和複合材料。

普及透明軟骨療法，實現高效關節運動

纖維軟骨是一種堅韌、緻​​密的纖維軟骨組織，存在於椎間盤、半月軟骨和恥骨聯合等身體部位。其特徵是由不同比例的白色纖維組織和軟骨組織混合而成。由於其高拉伸強度和有限的血液供應，纖維軟骨的內在癒合潛力有限，因此需要開發專門的修復技術。透明質酸軟骨是一種透明、有光澤的關節軟骨，可以保護關節的骨骼。它為關節運動提供光滑、低摩擦的表面，並有助於有效分配負荷。透明質酸軟骨受損會導致關節疼痛、僵硬和骨關節炎等症狀。其缺血性性質對修復和再生提出了重大挑戰。纖維軟骨和透明質酸軟骨修復的比較表明，由於解剖和功能差異，兩者都需要不同的方法。透明質軟骨廣泛存在於所有滑液關節中，對關節功能很重要，而纖維軟骨纖維較多，存在於身體的較少區域。纖維軟骨損傷更常見於特定區域，例如膝蓋或骨盆，而不是影響許多關節的透明軟骨問題。

最終用戶：由於複雜手術所需的先進設備和材料的存在，軟骨修復/軟骨再生在醫院的應用正在增加。

門診手術中心 (ASC) 是提供當天手術治療（包括診斷和預防程序）的醫療保健機構。在軟骨修復和再生領域，ASC 因其成本效益和便利性而成為越來越受患者歡迎的選擇。我們提供門診軟骨修復和再生服務，包括整形外科和運動醫學診所等專科診所。由於這些設施比醫院小，因此它們通常提供更個人化的患者護理方法。該醫院是一家綜合醫療機構，提供廣泛的醫療服務，包括高級軟骨修復和再生所需的複雜手術。門診手術中心為小手術提供高效且具成本效益的解決方案，診所提供個人化的非侵入性治療，而醫院則提供全面的護理和複雜的手術。提供者和製造商之間的合作繼續推動技術進步並改善所有這些醫療保健環境中的患者治療結果。

區域洞察

由於其完善的醫療基礎設施、有利的報銷方案以及主要市場參與者的存在，美國在採用創新軟骨修復解決方案方面處於領先地位。儘管面臨資源有限和醫療保健環境不利的報銷環境等挑戰，巴西和墨西哥等國家也顯示出市場成長潛力。亞太地區正在迅速崛起，成為軟骨修復和再生領域的主要參與者。這一成長的推動因素包括可支配收入的增加、醫療保健行業的擴張、對軟骨再生程序的認知不斷提高以及與生活方式相關的關節疾病患病率的上升。歐洲是 EMEA 軟骨修復和再生市場的關鍵地區，擁有先進的醫療保健系統、高昂的醫療成本和強大的法規結構。大型醫療保健公司的存在以及對研發的大量投資正在推動軟骨修復療法的創新。同時，由於醫療保健的取得和品質存在巨大差異，中東和非洲的成長正在放緩。

FPNV定位矩陣

FPNV定位矩陣對於評估軟骨修復/軟骨再生市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對軟骨修復/軟骨再生市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.軟骨修復/軟骨再生市場的市場規模和預測是多少？

2.在軟骨修復/軟骨再生市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.軟骨修復/軟骨再生市場的技術趨勢和法規結構是什麼？

4.軟骨修復/軟骨再生市場主要廠商的市場佔有率是多少？

5.進入軟骨修復/軟骨再生市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 關節炎和骨關節炎等骨關節疾病的盛行率
      • 交通事故和運動相關傷害的數量正在迅速增加。
      • 提高對軟骨生理學、解剖學和修復技術的認知
    • 抑制因素
      • 軟骨修復手術相關的高成本
    • 機會
      • 軟骨再生裝置的技術進步
      • 持續研究和開發軟骨再生
    • 任務
      • 與軟骨修復/軟骨再生手術相關的風險和併發症
  • 市場區隔分析
    • 治療模式：年輕患者首選細胞治療方法
    • 應用：更廣泛地使用透明軟骨療法來實現有效的關節運動
    • 最終用戶：由於複雜手術所需的先進設備和材料的存在，軟骨修復/軟骨再生在醫院環境中的應用正在增加。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章依治療模式分類的軟骨修復/軟骨再生市場

  • 基於細胞的
  • 非細胞基礎

第7章軟骨修復/軟骨再生市場：依應用分類

  • 纖維軟骨
  • 透明軟骨

第8章軟骨修復/軟骨再生市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第9章 北美和南美軟骨修復/軟骨再生市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太軟骨修復/軟骨再生市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲軟骨修復/軟骨再生市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 全錄輝獲得用於運動醫學膝蓋修復的新軟骨再生技術
    • FDA核准CartiHeal植入治療軟骨和骨軟骨缺陷
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4103B31E00C5

[190 Pages Report] The Cartilage Repair/Cartilage Regeneration Market size was estimated at USD 1.83 billion in 2023 and expected to reach USD 2.06 billion in 2024, at a CAGR 13.55% to reach USD 4.46 billion by 2030.

Cartilage repair and regeneration refers to a range of medical treatments and procedures aimed at restoring function and relieving pain in damaged joint cartilage. Cartilage is a resilient and smooth elastic tissue. This rubber-like padding covers and protects the ends of long bones at the joints and is a structural component of the rib cage, the ear, the nose, the bronchial tubes, the intervertebral discs, and many other body components. The cartilage repair/regeneration market encompasses medical procedures, tools, and treatments designed to repair, regenerate, or replace damaged cartilage. The prevalence of bone and joint disorders such as arthritis or osteoarthritis and the surge in the number of road accidents and sports-related injuries are driving the market growth. Rising awareness about cartilage physiology, anatomy, and repair techniques is also a fuel market. The costs associated with cartilage repair surgeries and the risks and complications involved in cartilage repair/regeneration procedures are restricting market development. Technological advancements in cartilage regeneration equipment are enhancing the efficacy of regenerative treatments. In addition, continuous research and development for cartilage regeneration are expanding its growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 1.83 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 4.46 billion
CAGR (%) 13.55%

Treatment Mode: Significant preference cell-based therapies for younger patients

Cell-based therapies involve using living cells to repair or regenerate cartilage tissue. These treatments often utilize chondrocytes or mesenchymal stem cells that can differentiate into cartilage cells. Cell-based chondrocyte transplantation represents an advanced medical treatment for cartilage defects and damage, typically employed in patients with localized cartilage loss. This process involves harvesting healthy cartilage cells from the patient's body, laboratory expansion of these cells, and subsequent reimplantation into the damaged area. Growth factor technology involves applying specific proteins known to enhance the growth and differentiation of cells, including chondrocytes. These biological molecules can be delivered through various methods, such as injections or embedded within scaffolds. On the other hand, non-cell-based therapies include treatments that do not directly involve living cells, such as tissue scaffolds and growth factors that aid in the natural process of cartilage repair. Cell-free composites are biomaterials that enable cartilage tissue regeneration without the direct use of living cells. Instead, these materials are engineered to mimic the extracellular matrix and support the migration and proliferation of native cells to the defect site. Tissue scaffolds are 3D structures that provide a supportive environment for the growth and development of new cartilage tissue. These scaffolds can be biodegradable or non-biodegradable and may be made from various materials, including natural and synthetic polymers, ceramics, or composites.

Application: Wider use of hyaline cartilage therapies for efficient joint movement

Fibrocartilage is a tough, dense, and fibrous type of cartilage tissue found in areas of the body, such as the intervertebral discs, menisci, and pubic symphysis. Various proportions of white fibrous tissue and cartilaginous tissue characterize it. Due to its high tensile strength and limited blood supply, fibrocartilage has limited intrinsic healing capability, which necessitates the development of specialized repair techniques. Hyaline cartilage is a transparent, glossy articular cartilage that protects the bones in joints. It provides a smooth, low-friction surface for joint movement and helps to distribute load effectively. Damage to hyaline cartilage can lead to joint pain, stiffness, and conditions like osteoarthritis. Its avascular nature poses significant challenges for repair and regeneration. When comparing fibrocartilage and hyaline cartilage repair, it is evident that both require distinct approaches due to their anatomical and functional differences. While fibrocartilage is more fibrous and is found in fewer body regions, hyaline cartilage is prevalent in all synovial joints and is critical for joint function. Fibrocartilage injuries are commonly associated with specific sites, such as the knee and pelvic region, instead of hyaline cartilage issues, which can affect many joints.

End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures

Ambulatory surgery centers(ASCs) are healthcare establishments that deliver same-day surgical care, including diagnostic and preventive procedures. In cartilage repair and regeneration, ASCs are an increasingly popular choice for patients due to their cost-effectiveness and convenience. Clinics, including those specialized, such as orthopedic or sports medicine clinics, offer outpatient cartilage repair and regeneration services. These facilities often provide a more personalized approach to patient care due to their smaller scale than hospitals. Hospitals are comprehensive medical facilities that offer a wide range of healthcare services, including complex surgeries required for advanced cartilage repair and regeneration. Ambulatory Surgery Centers offer efficient and cost-effective solutions for minor procedures, Clinics provide personalized and non-invasive treatments, and Hospitals are equipped for comprehensive care and complex surgeries. Collaborations among providers and manufacturers continue to drive technological advancements and improve patient outcomes in all these healthcare settings.

Regional Insights

The United States leads the region in the adoption of innovative cartilage repair solutions due to well-established healthcare infrastructure, favorable reimbursement scenarios, and the presence of key market players. Countries such as Brazil and Mexico also show potential for market growth, albeit with challenges such as resource limitations in healthcare settings and less favorable reimbursement environments. The Asia-Pacific region is rapidly emerging as a significant cartilage repair and regeneration player. This growth is propelled by increasing disposable incomes, an expanding healthcare sector, growing awareness about cartilage regeneration procedures, and the rising prevalence of lifestyle-related joint disorders. Europe is a major EMEA cartilage repair/regeneration market region, supported by sophisticated healthcare systems, high healthcare expenditure, and strong regulatory frameworks. The presence of leading healthcare companies and substantial investments in research and development fosters innovation in cartilage repair therapies. In contrast, the Middle East and Africa exhibit slower growth with significant healthcare access and quality disparities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cartilage Repair/Cartilage Regeneration Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cartilage Repair/Cartilage Regeneration Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Mode
    • Cell-Based
      • Chondrocyte Transplantation
      • Growth Factor Technology
    • Non-Cell-Based
      • Cell-Free Composites
      • Tissue Scaffolds
  • Application
    • Fibrocartilage
    • Hyaline Cartilage
  • End-User
    • Ambulatory Surgery Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cartilage Repair/Cartilage Regeneration Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cartilage Repair/Cartilage Regeneration Market?

3. What are the technology trends and regulatory frameworks in the Cartilage Repair/Cartilage Regeneration Market?

4. What is the market share of the leading vendors in the Cartilage Repair/Cartilage Regeneration Market?

5. Which modes and strategic moves are suitable for entering the Cartilage Repair/Cartilage Regeneration Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
      • 5.1.1.2. Surge in number of road accidents and sports-related injuries
      • 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with cartilage repair surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cartilage regeneration equipment
      • 5.1.3.2. Continuous research and development for cartilage regeneration
    • 5.1.4. Challenges
      • 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment Mode: Significant preference cell-based therapies for younger patients
    • 5.2.2. Application: Wider use of hyaline cartilage therapies for efficient joint movement
    • 5.2.3. End-User: Rising application of cartilage repair/cartilage regeneration in hospital settings due to presence of advanced equipment and materials needed for the complex procedures
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode

  • 6.1. Introduction
  • 6.2. Cell-Based
  • 6.3. Non-Cell-Based

7. Cartilage Repair/Cartilage Regeneration Market, by Application

  • 7.1. Introduction
  • 7.2. Fibrocartilage
  • 7.3. Hyaline Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Cartilage Repair/Cartilage Regeneration Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Smith+Nephew acquires novel cartilage regeneration technology for sports medicine knee repair
    • 12.3.2. FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
  • FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROCYTE TRANSPLANTATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY GROWTH FACTOR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-FREE COMPOSITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 136. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 146. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 156. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 166. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 176. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 186. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 196. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 206. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 216. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 226. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 247. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 248. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 258. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 268. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 278. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NON-CELL-BASED, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TREATMENT MODE, 2018-2023 (USD MILLION)
  • TABLE 288.